Spontan-bakterielle und sekundäre Peritonitis bei Patienten mit Leberzirrhose und Aszites

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Zentralblatt für Chirurgie

• Publication date

  2011-12-05

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1055/s-0031-1283815PMID 22144140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study

  2012cited by this paper
• NOD2 gene variants are a risk factor for culture‐positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis

  2012cited by this paper
• Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis.

  2012cited by this paper
• Initial microbial spectrum in severe secondary peritonitis and relevance for treatment

  2011cited by this paper
• The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection §

  2011cited by this paper
• Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients – a systematic review and meta‐analysis

  2011cited by this paper
• S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”

  2011cited by this paper
• Meta‐analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding – an updated Cochrane review

  2011cited by this paper
• [Secondary peritonitis].

  2011cited by this paper
• Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.

  2011cited by this paper
• Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?

  2010cited by this paper
• Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management.

  2010cited by this paper
• Toll‐like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients

  2010cited by this paper
• Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

  2010cited by this paper
• Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.

  2010cited by this paper
• Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

  2010cited by this paper
• Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

  2010cited by this paper
• EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

  2010cited by this paper
• The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

  2009cited by this paper
• β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis

  2009cited by this paper
• Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study

  2009cited by this paper
• Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.

  2009cited by this paper
• Identification of bacterial DNA in neutrocytic and non‐neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction

  2009cited by this paper
• Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.

  2008cited by this paper
• THE INNATE IMMUNE RESPONSE TO SECONDARY PERITONITIS

  2007cited by this paper
• Endotoxemia contributes to the immune paralysis in patients with cirrhosis.

  2007cited by this paper
• Risk factors for mortality after surgery in patients with cirrhosis.

  2007cited by this paper
• Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

  2007cited by this paper
• Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

  2006cited by this paper
• Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

  2006cited by this paper
• Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

  2006cited by this paper
• Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

  2005cited by this paper
• Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club

  2005cited by this paper
• Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.

  2005cited by this paper
• Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

  2002cited by this paper
• Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery

  2001cited by this paper
• Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis.

  2001cited by this paper
• Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

  2001cited by this paper
• Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation.

  2001cited by this paper
• In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease.

  2000cited by this paper
• Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.

  2000cited by this paper
• Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.

  1999cited by this paper
• Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels.

  1999cited by this paper
• Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

  1999cited by this paper
• Risk factors associated with intraabdominal infections: a prospective multicenter study

  1999cited by this paper
• Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group.

  1999cited by this paper
• Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

  1998cited by this paper
• Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients.

  1996cited by this paper
• Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

  1996cited by this paper
• Low protein concentration in cirrhotic ascites is related to low ascitic concentrations of immunoglobulins G and A

  1995cited by this paper
• Trimethoprim-Sulfamethoxazole for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhosis

  1995cited by this paper
• Ciprofloxacin and long‐term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial

  1995cited by this paper
• Chracteristics of the infections caused by Escherichia coli resistant, to norfloxacin in hospitalized cirrhotic patients

  1995cited by this paper
• Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis.

  1994cited by this paper
• Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

  1994cited by this paper
• Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

  1992cited by this paper
• Selective intestinal decontamination prevents spontaneous bacterial peritonitis.

  1991cited by this paper
• Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double‐blind, placebo‐controlled trial

  1990cited by this paper
• Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis.

  1990cited by this paper
• Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors

  1988cited by this paper
• Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.

  1986cited by this paper
• Opsonic activity of human ascitic fluid: A potentially important protective mechanism against spontaneous bacterial peritonitis

  1985cited by this paper
• Secondary Bacterial Peritonitis in Cirrhotic Patients With Ascites

  1984cited by this paper
• The Adjuvant Effect of Peritoneal Fluid in Experimental Peritonitis: Mechanism and Clinical Implications

  1984cited by this paper
• Ascitic Fluid Analysis in the Differentiation of Spontaneous Bacterial Peritonitis from Gastrointestinal Tract Perforation into Ascitic Fluid

  1984cited by this paper

• Cardiac Arrest Caused by Amniotic Fluid Embolism: a Report of Two Clinical Cases

  2024cites this paper
• Risk factors and outcome of bacterial infections in cirrhosis.

  2014cites this paper
• Kalkulierte Antibiotikatherapie bei intraabdominellen Infektionen – Fallbeispiele und evidenzbasierte Therapieempfehlungen

  2013cites this paper